Skip to content
The Waco

FDA approves first-of-its-kind treatment for most common form of pancreatic cancer

The U.S. Food and Drug Administration approved Rasonque on Wednesday, a first-of-its-kind treatment for pancreatic adenocarcinoma, the most common form of pancreatic cancer months ahead of its scheduled review deadline. Rasonque is a once-daily tablet that targets multiple forms of a protein call...

Sources and story details